• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of advisory committee members participating in meetings in the month who were granted waivers

Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the requirements set forth by 18 U.S.C. 208 are met. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.

Information is current as of December 31, 2013.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent Granted Waivers
Oct 2012N/A0
Nov 2012N/A.88
Dec 2012N/A0
Jan 2013N/A0
Feb 2013N/A0
Mar 2013N/A2.75
Apr 2013N/A0
May 2013N/A2.15
Jun 2013N/A0
Jul 2013N/A0
Aug 2013N/A0
Sep 2013N/A0

FY 2013 Overall: 0.52%

Total number of advisory committee members participating in meetings in the month who were granted waivers

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetWaivers Granted
Oct 2012N/A0
Nov 2012N/A1
Dec 2012N/A0
Jan 2013N/A0
Feb 2013N/A0
Mar 2013N/A3
Apr 2013N/A0
May 2013N/A2
Jun 2013N/A0
Jul 2013N/A0
Aug 2013N/A0
Sep 2013N/A0

FY 2013 Total: 6

Total number of advisory committee members participating in meetings in the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetCommittee Members
Oct 2012N/A83
Nov 2012N/A114
Dec 2012N/A115
Jan 2013N/A91
Feb 2013N/A96
Mar 2013N/A109
Apr 2013N/A97
May 2013N/A93
Jun 2013N/A83
Jul 2013N/A75
Aug 2013N/A69
Sep 2013N/A140

FY 2013 Total: 1,165

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.